Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts NKGen Biotech, Inc. Nyse

Equities

NKGN

US65488A1016

Market Closed - Nyse
Other stock markets
 16:00:01 2024-05-16 EDT 		5-day change 1st Jan Change
1.14 USD 0.00% Intraday chart for NKGen Biotech, Inc. -10.40% -86.27%
04-29 Nkgen Biotech Announces FDA Clearance of Investigational New Drug Application for SNK01 NK Cell Therapy in Parkinson's Disease CI
04-29 NKGen Biotech, Inc. announced that it has received $0.55 million in funding from FirstFire Capital Management LLC, Meteora Capital, LLC, Glazer Capital, LLC, Meteora Strategic Capital, LLC, Sandia Investment Managment LP CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bearish

Bearish

Resistance 3.580 3.580 3.470
Spread/Res.-68.16%-68.16%-67.15%
Spread/Supp.+28.09%+28.09%+0.00%
Support 0.8900 0.8900 1.140
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. NKGN Stock
  5. Charts NKGen Biotech, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW